Andersons pediatric cardiology 2086

correctionoftetralogyoffallot.AnnThorac
Surg.2006;81:968–975.
53.MichielonG,MarinoB,OrecchioG,etal.
ImpactofDEL22q11,trisomy21,andother
geneticsyndromesonsurgicaloutcomeof
conotruncalheartdefects.JThoracCardiovasc
Surg.2009;138:565–570.
54.O'ByrneML,YangW,Mercer-RosaL,etal.
22q11.2deletionsyndromeisassociatedwith
increasedperioperativeeventsandinfants
undergoinginfantoperativecorrectionotruncus
arteriosuscommunisorinterruptedaorticarch.J
ThoracCardiovascSurg.2014;148:1597–1605.
55.HalfordS,LindsayE,NayuduM,etal.Lowcopy-numberrepeatsequencesflankthe
DiGeorge/velo-cardio-facialsyndromelociat
22q11.HumMolGenet.1993;2:191–196.
56.BaldiniA,FulcoliFG,IllingworthE.Tbx1:
transcriptionalanddevelopmentalfunctions.
CurrTopDevBiol.2017;122:223–243.
57.GoldmuntzE,DriscollDA,EmanuelBS,etal.
Evaluationofpotentialmodifiersofthecardiac
phenotypeinthe22q11.2deletionsyndrome.
BirthDefectsResAClinMolTeratol.
2009;85:125–129.
58.MorrisCA,DiltsC,DempseySA,LeonardCO,
BlackburnB.Thenaturalhistoryofwilliams


syndrome:physicalcharacteristics.JPediatr.
1988;113:318–326.
59.AmericanAcademyofPediatrics,Committeeon

Genetics.Healthcaresupervisionforchildren
withwilliamssyndrome.Pediatrics.
2001;107:1192–1204.
60.WrenC,OslizlokP,BullC.Naturalhistoryof
supravalvularaorticstenosisandpulmonary
arterystenosis.JAmCollCardiol.
1990;15:1625–1630.
61.DridiSM,FoucaultBertaudA,IgondjoTchenS,
etal.Vascularwallremodelinginpatientswith
supravalvularaorticstenosisandWilliams
Beurensyndrome.JVascRes.2005;42:190–201.
62.DelPasquaA,RinelliG,ToscanoA,etal.New
findingsconcerningcardiovascular
manifestationsemergingfromlong-termfollowupof150patientswiththewilliams-beuren
syndrome.CardiolYoung.2009;19:563–567.
63.MedleyJ,RussoP,TobiasJD.Perioperativecare
ofpatientswithWilliamssyndrome.Paediatr
Anaesth.2005;15:243–247.
64.GiordanoU,TurchettaA,GiannottiA,etal.
Exercisetestingand24-hourambulatoryblood
pressuremonitoringinchildrenwithWilliams
syndrome.PediatrCardiol.2001;22:509–511.
65.EwartAK,MorrisCA,AtkinsonD,etal.


Hemizygosityattheelastinlocusin
developmentaldisorder,williamssyndrome.Nat
Genet.1993;5:11–16.
66.TidymanWE,RauenKA.TheRASopathies:
developmentalsyndromesofRas/MAPK

pathwaydysregulation.CurrOpinGenetDev.
2009;19:230–236.
67.TartagliaM,ZampinoG,GelbBD.Noonan
syndrome:clinicalaspectsandmolecular
pathogenesis.MolSyndromol.2010;1:2–26.
68.DigilioMC,ContiE,SarkozyA,etal.Grouping
ofmultiple-lentigines/LEOPARDandNoonan
syndromesonthePTPN11gene.AmJHum
Genet.2002;71:389–394.
69.SarkozyA,ContiE,DigilioMC,etal.Clinical
andmolecularanalysisof30patientswith
multiplelentiginesLEOPARDsyndrome.JMed
Genet.2004;41:e68.
70.NarumiY,AokiY,NiihoriT,etal.Molecularand
clinicalcharacterizationofcardio-faciocutaneous(CFC)syndrome.AmJMedGenet.
2007;143A:799–807.
71.GrippKW,LinAE,StableyDL,etal.HRAS
mutationanalysisincostellosyndrome:
genotypeandphenotypecorrelation.AmJMed
Genet.2006;140A:1–7.
72.BurchM,SharlandM,ShinebourneE,etal.